VOYA INVESTMENT MANAGEMENT LLC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1068837
ATLANTA, GA
Position in ARWR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$39,409,675
-$1,729,611 QoQ
Shares Held
483,495
-26.3% QoQ
Ownership
0.342%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#44
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 91%
None 9%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VOYA INVESTMENT MANAGEMENT LLC holds $1,414,582,516 across 196 Biotechnology names. ARWR ranks #10 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
505,219 | $250,957,432 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
571,618 | $70,068,932 | |
| 3 | SRRK |
Scholar Rock Holding Corp
|
890,607 | $48,983,385 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
124,442 | $46,251,357 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
819,253 | $45,009,759 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
539,319 | $43,992,249 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
122,227 | $40,920,376 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,505 | $40,844,986 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,409,675 | 483,495 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $41,139,286 | 656,129 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $28,065,110 | 422,731 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $4,742,925 | 137,516 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $841,571 | 53,264 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $410,024 | 32,184 | Shares | Defined | 2025-06-18 | |
| 2024-12-31 | $1,011,308 | 53,793 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $5,818,088 | 300,366 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $7,157,463 | 275,393 | Shares | Defined | 2025-02-07 | |
| 2024-03-31 | $5,420,843 | 189,540 | Shares | Defined | 2025-02-07 | |
| 2023-12-31 | $5,983,095 | 195,526 | Shares | Defined | 2025-02-07 | |
| 2023-09-30 | $5,052,177 | 188,023 | Shares | Defined | 2025-02-07 | |
| 2023-06-30 | $8,203,403 | 230,045 | Shares | Defined | 2025-02-07 | |
| 2023-03-31 | $6,069,506 | 238,957 | Shares | Defined | 2025-02-07 | |
| 2022-12-31 | $10,763,082 | 265,362 | Shares | Defined | 2025-02-07 | |
| 2022-09-30 | $8,621,059 | 260,849 | Shares | Defined | 2025-02-07 | |
| 2022-06-30 | $8,031,787 | 228,111 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $6,904,570 | 150,132 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,050,937 | 106,349 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $16,750,779 | 268,313 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $22,213,564 | 268,215 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $18,605,259 | 280,580 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $22,692,665 | 295,747 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $15,521,362 | 360,459 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $16,049,877 | 371,611 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $13,606,281 | 472,933 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||